BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16841257)

  • 21. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece.
    Stefos A; Gatselis N; Zachou K; Rigopoulou E; Hadjichristodoulou C; Dalekos GN
    Eur J Intern Med; 2009 Jan; 20(1):35-43. PubMed ID: 19237090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma.
    Abnet CC; Freedman ND; Hollenbeck AR; Fraumeni JF; Leitzmann M; Schatzkin A
    Eur J Cancer; 2008 Feb; 44(3):465-71. PubMed ID: 18221867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of visceral adiposity with oesophageal and junctional adenocarcinomas.
    Beddy P; Howard J; McMahon C; Knox M; de Blacam C; Ravi N; Reynolds JV; Keogan MT
    Br J Surg; 2010 Jul; 97(7):1028-34. PubMed ID: 20632268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study.
    Merry AH; Schouten LJ; Goldbohm RA; van den Brandt PA
    Gut; 2007 Nov; 56(11):1503-11. PubMed ID: 17337464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005-2016.
    Safi S; Ahmadzade M; Karimi S; Akbari ME; Rouientan H; Abolhosseini M; Rezaei Kanavi M; Khorrami Z
    BMC Cancer; 2023 Sep; 23(1):924. PubMed ID: 37777736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RELATIONSHIP BETWEEN BODY MASS INDEX AND PATOHISTOLOGICAL FEATURES OF THYROID CANCER.
    Zubčić Ž; Mihalj H; Šestak A; Včeva A; Abičić I; Mendeš T
    Acta Clin Croat; 2022 Nov; 61(3):469-475. PubMed ID: 37492362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway.
    Cheng Y; Zhang Z; Gao P; Lai H; Zhong W; Feng N; Yang Y; Yu H; Zhang Y; Han Y; Dong J; He Z; Huang R; Zhai Q
    EMBO Mol Med; 2023 Jul; 15(7):e17230. PubMed ID: 37272212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of colorectal cancer according to obesity status at four-year intervals: a nationwide population-based cohort study.
    Seo JY; Jin EH; Chung GE; Kim YS; Bae JH; Yim JY; Han KD; Yang SY
    Sci Rep; 2023 Jun; 13(1):8928. PubMed ID: 37264099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constant Association between Low High-Density Lipoprotein Cholesterol and Gastric Cancer Regardless of Site.
    Nam SY; Jeong J; Jeon SW
    J Obes Metab Syndr; 2023 Jun; 32(2):141-150. PubMed ID: 37127344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Influence of Obesity on Melanoma and Sentinel Lymph Node Diagnosis: A Retrospective Monocentric Study in 1001 Patients.
    Almeida Oliveira F; Klose J; Schulze HJ; Ribeiro Teixeira M; Dermietzel A; Wellenbrock S; Herter-Sprie GS; Hirsch T; Kueckelhaus M
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipids as Targets for Renal Cell Carcinoma Therapy.
    Stepanovska Tanturovska B; Manaila R; Fabbro D; Huwiler A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a multicenter prospective cohort study.
    Hatta W; Koike T; Asonuma S; Okata H; Uno K; Oikawa T; Iwai W; Yonechi M; Fukushi D; Kayaba S; Kikuchi R; Ohyauchi M; Fushiya J; Maejima R; Abe Y; Kawamura M; Honda J; Kondo Y; Dairaku N; Norita K; Watanabe K; Takahashi K; Echigo H; Abe Y; Endo H; Okata T; Hoshi T; Nakamura T; Nakaya N; Iijima K; Masamune A;
    J Gastroenterol; 2023 May; 58(5):433-443. PubMed ID: 36786863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addictive behavior and incident gallstone disease: A dose-response meta-analysis and Mendelian randomization study.
    Bai Y; Zhang M; Cui H; Shan X; Gu D; Wang Y; Tang M; Wang X; Jiang X; Zhang B
    Front Nutr; 2022; 9():940689. PubMed ID: 36299995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.
    Shin HS; Jun BG; Yi SW
    Clin Mol Hepatol; 2022 Oct; 28(4):773-789. PubMed ID: 35934813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies.
    Ahmadinezhad M; Arshadi M; Hesari E; Sharafoddin M; Azizi H; Khodamoradi F
    Epidemiol Health; 2022; 44():e2022050. PubMed ID: 35638225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BMI changes and the risk of lung cancer in male never-smokers: A prospective cohort study.
    Wu Z; Xie S; Wang F; Chen S; Su K; Li F; Cui H; Cao W; Yu Y; Qin C; Zheng Y; Dong X; Yang Z; Luo Z; Zhao L; Xu Y; Chen H; Li J; Wang G; Wu S; Dai M; Li N; He J
    Cancer Med; 2022 Mar; 11(5):1336-1346. PubMed ID: 35102723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifestyle, WCRF/AICR Recommendations, and Esophageal Adenocarcinoma Risk: A Systematic Review of the Literature.
    Nucci D; Marino A; Realdon S; Nardi M; Fatigoni C; Gianfredi V
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive review of the impact of obesity on plasma cell disorders.
    Parikh R; Tariq SM; Marinac CR; Shah UA
    Leukemia; 2022 Feb; 36(2):301-314. PubMed ID: 34654885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment.
    Imai K; Takai K; Miwa T; Maeda T; Hanai T; Shiraki M; Suetsugu A; Shimizu M
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.